Core Viewpoint - Rosen Law Firm is reminding investors who bought or sold Cepton, Inc. (NASDAQ: CPTN) common stock between July 29, 2024, and January 6, 2025, of the December 8, 2025, lead plaintiff deadline for a class action lawsuit [1]. Group 1: Class Action Details - Investors who purchased or sold Cepton common stock during the specified Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - To participate in the class action, interested parties can visit the provided link or contact Phillip Kim, Esq. for more information [3][6]. - A lead plaintiff must file a motion with the Court by December 8, 2025, to represent other class members in the litigation [3]. Group 2: Law Firm Credentials - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions, highlighting its own achievements in this area [4]. - The firm has secured significant settlements for investors, including over $438 million in 2019, and has been recognized as a leader in the field of securities class action settlements [4]. Group 3: Case Allegations - The lawsuit alleges that Cepton's management made materially false and misleading statements regarding the company's business and operations during the Class Period [5]. - Specific allegations include the failure to disclose a credible third-party bid valuing Cepton at more than double the Koito Acquisition, and the Board's lack of meaningful exploration of this offer [5]. - As a result, shareholders were deprived of the opportunity to make an informed decision regarding the Koito Acquisition [5].

Core Points - A class action lawsuit has been filed against Cepton, Inc. in the United States District Court for the Northern District of California on behalf of investors who purchased Cepton common stock between July 29, 2024, and January 6, 2025 [6] - The lawsuit alleges that Cepton's management made materially false and misleading statements regarding the company's business and operations, including failing to disclose a credible third-party bid that valued Cepton at more than double the Koito Acquisition [2] Allegation Details - The complaint claims that Cepton's Board of Directors did not adequately explore a third-party bid and failed to disclose its terms when recommending the Koito Acquisition to shareholders [2] - As a result, shareholders were deprived of the opportunity to meaningfully consider the acquisition, leading to materially false and misleading public statements by the defendants [2] Next Steps - Investors who acquired Cepton shares and suffered losses are encouraged to contact the law firm for more information regarding their rights and potential claims [3] - There is a deadline of December 8, 2025, for investors to apply to be appointed as lead plaintiff in the lawsuit [6]

Core Viewpoint - Saxena White P.A. has initiated a securities class action lawsuit against Cepton, Inc. and its executives, alleging violations of the Securities Exchange Act related to a "take-private" acquisition by Koito Manufacturing Co., Ltd. The lawsuit claims that Cepton misled shareholders regarding the true value of the company and failed to disclose critical information during the merger process [1][8][10]. Group 1: Class Action Details - The class action expands the class period from July 29, 2024, to January 7, 2025, and includes claims on behalf of all individuals and entities that sold Cepton common stock during this period [2]. - The lawsuit is filed in the U.S. District Court for the Northern District of California, and investors wishing to serve as lead plaintiff must file a motion by December 8, 2025 [3]. Group 2: Company Background - Cepton, based in San Jose, California, specializes in high-performance lidar technologies aimed at enhancing safety and enabling autonomy in automotive and smart infrastructure markets [4]. - Koito Manufacturing Co., Ltd. invested $200 million in Cepton, acquiring 30.1% of Cepton's voting power and two seats on its Board of Directors [4]. Group 3: Merger and Valuation Issues - Cepton received a credible acquisition proposal from a third party valued at more than double the merger price of $3.17 per share, which was not disclosed to shareholders [5][9]. - A new production award estimated to generate approximately $40 million in revenue over three years was not disclosed to the Board prior to the merger approval, affecting the fairness opinion provided by Cepton's financial advisor [6][9]. Group 4: Allegations of Misleading Information - The class action alleges that Cepton's executives authorized materially false and misleading proxy statements that omitted crucial information regarding the merger, leading shareholders to undervalue their stock [8][10]. - The lawsuit claims that shareholders were deprived of essential information that would have influenced their decision to vote on the merger, resulting in financial losses [9][10].

Core Viewpoint - Rosen Law Firm is encouraging investors of Cepton, Inc. who incurred losses exceeding $100,000 during the specified Class Period to seek legal counsel before the December 8, 2025 deadline for lead plaintiff applications [1][2]. Group 1: Class Action Details - The class action pertains to Cepton, Inc. common stock transactions between July 29, 2024, and January 6, 2025, during which investors may be entitled to compensation without upfront costs through a contingency fee arrangement [2][5]. - The lawsuit alleges that Cepton's management made materially false and misleading statements regarding the company's business and operations, including failing to disclose a credible third-party bid that valued Cepton at more than double the Koito Acquisition [5]. Group 2: Legal Representation - Investors are advised to select qualified legal counsel with a proven track record in securities class actions, as many firms may lack the necessary experience and resources [4]. - The Rosen Law Firm has a history of successful settlements in securities class actions, including a notable $438 million recovery for investors in 2019 [4].

Core Viewpoint - Rosen Law Firm is reminding investors who bought or sold Cepton, Inc. (NASDAQ: CPTN) common stock between July 29, 2024, and January 6, 2025, of the December 8, 2025, deadline to become a lead plaintiff in a class action lawsuit [1]. Group 1: Class Action Details - Investors who purchased or sold Cepton common stock during the specified Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - To participate in the class action, interested parties can visit the provided link or contact Phillip Kim, Esq. for more information [3][6]. - A lead plaintiff is required to file a motion with the Court by December 8, 2025, to represent other class members in the litigation [3]. Group 2: Law Firm Credentials - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions, highlighting its own achievements in this area [4]. - The firm has secured significant settlements for investors, including over $438 million in 2019 and has been ranked highly for its performance in securities class action settlements [4]. Group 3: Case Allegations - The lawsuit alleges that during the Class Period, Cepton's management made materially false and misleading statements regarding the company's business and operations [5]. - Specific allegations include the failure to disclose a credible third-party bid valuing Cepton at more than double the Koito Acquisition and the Board's lack of meaningful exploration of this offer [5]. - As a result, shareholders were deprived of the opportunity to make an informed decision regarding the Koito Acquisition [5].

NEW YORK, Dec. 02, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers or sellers of common stock of Cepton, Inc. (NASDAQ: CPTN) between July 29, 2024 and January 6, 2025, both dates inclusive (the “Class Period”), of the important December 8, 2025 lead plaintiff deadline. SO WHAT: If you purchased or sold Cepton common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fe ...

Core Insights - Class actions have been initiated on behalf of stockholders of Cepton, Inc. and MoonLake Immunotherapeutics, with specific deadlines for investors to petition the court to serve as lead plaintiff [1] MoonLake Immunotherapeutics - The lawsuit alleges that MoonLake Immunotherapeutics misled investors regarding its drug candidate sonelokimab (SLK), claiming it was superior to competing monoclonal antibodies [6] - The complaint states that MoonLake and its executives promoted SLK's Nanobody structure as having unique clinical advantages while failing to disclose it targeted the same molecules as UCB's BIMZELX and had no proven superiority [6] - Following the announcement of Phase 3 results on September 28, 2025, which showed SLK did not match BIMZELX's efficacy, MoonLake's stock fell nearly 90%, resulting in significant investor losses [6] - On September 29, 2025, MoonLake filed a current report with the SEC indicating that intercurrent events in the higher-than-expected placebo arm prevented the study from achieving statistical significance [6] - The stock plummeted 89.9% on September 29, 2025, following this news [6] Cepton, Inc. - The lawsuit against Cepton alleges that defendants made materially false and misleading statements and failed to disclose tax fraud and bribery to cover it up [6] - The complaint claims that as a result of these actions, the legal risks facing the company were understated, leading to materially false and misleading statements about its business and operations [6] - Investors suffered damages when the true details of the situation became public [6]

New York, New York--(Newsfile Corp. - December 1, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers or sellers of common stock of Cepton, Inc. (NASDAQ: CPTN) between July 29, 2024 and January 6, 2025, both dates inclusive (the "Class Period"), of the important December 8, 2025 lead plaintiff deadline.SO WHAT: If you purchased or sold Cepton common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a c ...

Accessibility StatementSkip Navigation PHILADELPHIA, Dec. 1, 2025 /PRNewswire/ -- National plaintiffs' law firm Berger Montague PC announces a class action lawsuit against Cepton, Inc. (NASDAQ: CPTN) ("Cepton" or the "Company") on behalf of investors who purchased or sold Cepton shares during the period of July 29, 2024 through January 6, 2025 (the "Class Period"). Investor Deadline: Investors who purchased or sold Cepton securities during the Class Period may, no later than December 8, 2025, seek to be ...

Core Viewpoint - Rosen Law Firm is urging investors of Cepton, Inc. to secure legal counsel before the December 8, 2025 deadline related to a securities class action lawsuit concerning misleading statements made by the company during the class period from July 29, 2024, to January 6, 2025 [1][5]. Group 1: Legal Action Details - Investors who purchased or sold Cepton common stock during the specified class period may be eligible for compensation without incurring out-of-pocket fees through a contingency fee arrangement [2]. - To participate in the class action, investors must act before the lead plaintiff deadline of December 8, 2025, and can do so by contacting Rosen Law Firm [3][6]. Group 2: Allegations Against Cepton - The lawsuit alleges that Cepton's management made materially false and misleading statements regarding the company's business and operations, particularly concerning a third-party bid that valued Cepton at more than double the Koito Acquisition [5]. - It is claimed that Cepton's Board of Directors failed to adequately explore this offer and did not disclose its terms, depriving shareholders of the opportunity to make an informed decision regarding the Koito Acquisition [5]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes its experience and success in handling securities class actions, having achieved significant settlements, including the largest securities class action settlement against a Chinese company [4]. - The firm has consistently ranked highly in securities class action settlements and has recovered hundreds of millions of dollars for investors, with over $438 million secured in 2019 alone [4].